NewcelX Ltd. (NCEL) stock
NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)
Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –
NewcelX cash
Cash and short-term investments held at the end of each period.
NewcelX's cash was $710.00K at Jun 30, 2026. For fiscal 2025 it was $2.20M, up 238.6% from the year before. The highest annual figure on record is $5.43M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.20M | +238.6% |
| FY2024 | Dec 31, 2024 | $650.00K | -43.3% |
| FY2023 | Dec 31, 2023 | $1.15M | -41.9% |
| FY2022 | Dec 31, 2022 | $1.97M | -63.7% |
| FY2021 | Dec 31, 2021 | $5.43M | +5695.7% |
| FY2020 | Dec 31, 2020 | $93.71K | -57.5% |
| FY2019 | Dec 31, 2019 | $220.27K | +3198.4% |
| FY2018 | Dec 31, 2018 | $6.68K | -99.7% |
| FY2017 | Dec 31, 2017 | $2.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $710.00K | +28.4% |
| Q4 FY2025 | Dec 31, 2025 | $2.20M | +92.1% |
| Q2 FY2025 | Jun 30, 2025 | $299.00K | -81.9% |
| Q4 FY2024 | Dec 31, 2024 | $650.00K | -67.1% |
| Q2 FY2024 | Jun 30, 2024 | $552.76K | -59.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.15M | -78.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.65M | -76.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.97M | +2006.5% |
| Q2 FY2022 | Jun 30, 2022 | $1.35M | +831.3% |
| Q4 FY2021 | Dec 31, 2021 | $5.43M | +2365.7% |
| Q2 FY2021 | Jun 30, 2021 | $7.09M | +106101.2% |
| Q4 FY2020 | Dec 31, 2020 | $93.71K | -95.7% |
| Q2 FY2020 | Jun 30, 2020 | $145.40K | – |
| Q4 FY2019 | Dec 31, 2019 | $220.27K | – |
| Q4 FY2018 | Dec 31, 2018 | $6.68K | – |
| Q4 FY2017 | Dec 31, 2017 | $2.18M | – |
See a number that looks wrong?